The Mechanism of Action of Biguanides: New Answers to a Complex Question.

biguanides cancer complex I metabolism metformin redox

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
30 Jun 2022
Historique:
received: 25 05 2022
revised: 20 06 2022
accepted: 23 06 2022
entrez: 9 7 2022
pubmed: 10 7 2022
medline: 10 7 2022
Statut: epublish

Résumé

Biguanides are a family of antidiabetic drugs with documented anticancer properties in preclinical and clinical settings. Despite intensive investigation, how they exert their therapeutic effects is still debated. Many studies support the hypothesis that biguanides inhibit mitochondrial complex I, inducing energy stress and activating compensatory responses mediated by energy sensors. However, a major concern related to this "complex" model is that the therapeutic concentrations of biguanides found in the blood and tissues are much lower than the doses required to inhibit complex I, suggesting the involvement of additional mechanisms. This comprehensive review illustrates the current knowledge of pharmacokinetics, receptors, sensors, intracellular alterations, and the mechanism of action of biguanides in diabetes and cancer. The conditions of usage and variables affecting the response to these drugs, the effect on the immune system and microbiota, as well as the results from the most relevant clinical trials in cancer are also discussed.

Identifiants

pubmed: 35804992
pii: cancers14133220
doi: 10.3390/cancers14133220
pmc: PMC9265089
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : Italian Association for Cancer Research
ID : IG 2021, code n. 25833
Organisme : Istituto Pasteur
ID : Call 2018 Anna Tramontano
Organisme : Sapienza University of Rome
ID : RG12117A61923A6F
Organisme : Fondazione Umberto Veronesi
ID : Post-Doctoral Fellowship 2022

Références

Br J Clin Pharmacol. 1981 Aug;12(2):235-46
pubmed: 7306436
Mol Cell. 2021 Sep 16;81(18):3848-3865.e19
pubmed: 34547241
Diabetologia. 1978 Feb;14(2):75-87
pubmed: 344119
Cell Metab. 2013 Jan 8;17(1):113-24
pubmed: 23274086
Pharmacogenet Genomics. 2011 Dec;21(12):837-50
pubmed: 21989078
Cancer Res. 2016 Jul 1;76(13):3904-15
pubmed: 27216187
Clin Cancer Res. 2018 Aug 15;24(16):4030-4043
pubmed: 29691295
J Clin Invest. 2010 Jul;120(7):2355-69
pubmed: 20577053
J Clin Oncol. 2012 Jan 10;30(2):164-71
pubmed: 22162568
Cancer Prev Res (Phila). 2010 Nov;3(11):1451-61
pubmed: 20947488
J Biol Chem. 2007 Aug 24;282(34):25041-52
pubmed: 17591776
Cell Biosci. 2020 Mar 10;10:31
pubmed: 32175074
Eur J Clin Pharmacol. 1974 Oct 4;7(6):433-48
pubmed: 4439867
Diabetes Obes Metab. 2017 Mar;19(3):356-363
pubmed: 27862873
Biomed Mass Spectrom. 1974 Oct;1(5):320-2
pubmed: 4464999
Sci Rep. 2016 Oct 20;6:35788
pubmed: 27762347
Diabetes. 1977 Jul;26(7):628-31
pubmed: 406157
Eur J Pharmacol. 2019 Nov 15;863:172696
pubmed: 31562866
Diabetes. 2002 Oct;51(10):2944-50
pubmed: 12351431
Aging Cell. 2013 Jun;12(3):489-98
pubmed: 23521863
EMBO J. 2008 Jan 23;27(2):433-46
pubmed: 18200046
Cell Metab. 2016 Nov 8;24(5):716-727
pubmed: 27746050
Cell Rep. 2019 Nov 5;29(6):1511-1523.e5
pubmed: 31693892
Diabetes Res Clin Pract. 2014 Oct;106(1):e3-6
pubmed: 25172519
Drug Metab Dispos. 2007 Oct;35(10):1956-62
pubmed: 17600084
Ann N Y Acad Sci. 1968 Mar 26;148(3):820-32
pubmed: 5241479
J Clin Invest. 2001 Oct;108(8):1167-74
pubmed: 11602624
Proc Natl Acad Sci U S A. 2003 May 13;100(10):5902-7
pubmed: 12719534
Pediatr Blood Cancer. 2018 Sep;65(9):e27224
pubmed: 29856514
Biochem J. 2014 Sep 15;462(3):475-87
pubmed: 25017630
Nature. 2014 Apr 3;508(7494):108-12
pubmed: 24670634
Front Endocrinol (Lausanne). 2018 Dec 17;9:753
pubmed: 30619086
Diabetes Care. 2012 Feb;35(2):299-304
pubmed: 22266734
Diabetologia. 2011 Dec;54(12):3101-10
pubmed: 21947382
J Biol Chem. 2019 Feb 22;294(8):2839-2853
pubmed: 30591586
Diabetes Obes Metab. 2003 Mar;5(2):93-8
pubmed: 12630933
Diabetes Care. 1987 Jan-Feb;10(1):62-7
pubmed: 3552515
Diabetologia. 2011 Feb;54(2):339-49
pubmed: 20972533
Drug Metab Dispos. 2007 Aug;35(8):1333-40
pubmed: 17496207
Cancer Prev Res (Phila). 2015 Jun;8(6):518-27
pubmed: 25804611
Mol Cell. 2008 Apr 25;30(2):214-26
pubmed: 18439900
PLoS One. 2017 May 2;12(5):e0176242
pubmed: 28464031
Br J Cancer. 2012 Mar 13;106(6):1117-22
pubmed: 22361631
Cancer Cell. 2013 Feb 11;23(2):143-58
pubmed: 23352126
Clin Pharmacokinet. 2011 Feb;50(2):81-98
pubmed: 21241070
J Med Genet. 1985 Oct;22(5):361-6
pubmed: 4078865
Mol Cell Biochem. 2008 Jan;308(1-2):75-83
pubmed: 17909944
Biochem Pharmacol. 2007 Jul 15;74(2):359-71
pubmed: 17509534
Arzneimittelforschung. 1972 May;22(5):937-46
pubmed: 5068215
J Epidemiol Glob Health. 2020 Mar;10(1):107-111
pubmed: 32175717
Diabetologia. 1994 Aug;37(8):826-32
pubmed: 7988785
Oncogene. 2019 May;38(19):3743-3755
pubmed: 30670777
Int Immunol. 2019 Mar 28;31(4):187-198
pubmed: 30508092
Oncotarget. 2016 Feb 23;7(8):9538-49
pubmed: 26843621
Trends Biochem Sci. 2016 Mar;41(3):211-218
pubmed: 26778478
J Res Med Sci. 2014 Jul;19(7):658-64
pubmed: 25364368
Diabetes Care. 2016 Feb;39(2):198-205
pubmed: 26285584
Science. 2012 Aug 31;337(6098):1062-5
pubmed: 22936770
Diabetes Care. 2006 Apr;29(4):759-64
pubmed: 16567811
J Clin Invest. 2005 Dec;115(12):3587-93
pubmed: 16284649
Nat Rev Dis Primers. 2015 Jul 23;1:15019
pubmed: 27189025
Cell Metab. 2013 Apr 2;17(4):491-506
pubmed: 23562075
Cell Metab. 2019 Feb 5;29(2):285-302.e7
pubmed: 30415923
Clin Pharmacokinet. 1991 Oct;21(4):308-17
pubmed: 1760902
Diabetes Res Clin Pract. 2017 Sep;131:208-216
pubmed: 28778047
Nat Med. 2018 Dec;24(12):1919-1929
pubmed: 30397356
Cell Metab. 2016 Apr 12;23(4):569-70
pubmed: 27076070
Diabetes. 1960 May-Jun;9:178-82
pubmed: 13857072
Biomed Pharmacother. 2011 Sep;65(6):451-5
pubmed: 21880461
J Pharm Pharm Sci. 2009;12(3):388-96
pubmed: 20067714
J Clin Oncol. 2011 Oct 10;29(29):3869-76
pubmed: 21911723
Interface Focus. 2017 Apr 6;7(2):20160109
pubmed: 28382202
Nature. 2015 Dec 10;528(7581):262-266
pubmed: 26633628
Diabetologia. 1973 Feb;9(1):6-12
pubmed: 4701477
Annu Rev Biochem. 2013;82:551-75
pubmed: 23527692
Am J Physiol Renal Physiol. 2007 Feb;292(2):F682-90
pubmed: 17018840
Arztl Forsch. 1966 Aug 10;20(8):415-9
pubmed: 6014705
Biochem J. 2008 Jun 1;412(2):211-21
pubmed: 18387000
Oncogene. 2013 Jul 25;32(30):3483-90
pubmed: 23208510
Obes Res. 1998 Jan;6(1):47-53
pubmed: 9526970
Front Endocrinol (Lausanne). 2019 May 07;10:294
pubmed: 31133988
Nature. 2022 Mar;603(7899):159-165
pubmed: 35197629
Curr Med Chem. 2017;24(31):3397-3412
pubmed: 28393693
Clin Sci (Lond). 1980 Feb;58(2):153-5
pubmed: 6987032
JCI Insight. 2018 Dec 6;3(23):
pubmed: 30518693
Pharmacogenet Genomics. 2012 Nov;22(11):820-7
pubmed: 22722338
Gastroenterology. 2006 Nov;131(5):1553-60
pubmed: 17101328
PLoS One. 2014 Feb 24;9(2):e89938
pubmed: 24587137
Xenobiotica. 1994 Jan;24(1):49-57
pubmed: 8165821
Proc Natl Acad Sci U S A. 2013 Jan 15;110(3):972-7
pubmed: 23277563
Int J Obes (Lond). 2014 Dec;38(12):1555-64
pubmed: 24531647
BMJ. 2005 Jun 4;330(7503):1304-5
pubmed: 15849206
Proc Natl Acad Sci U S A. 2022 Mar 8;119(10):e2122287119
pubmed: 35238637
J Biol Chem. 2018 Sep 21;293(38):14891-14904
pubmed: 30087121
Cell Metab. 2015 Feb 3;21(2):159-162
pubmed: 25651170
Cell Metab. 2016 Nov 8;24(5):728-739
pubmed: 27746051
Arch Intern Med. 2008 Oct 27;168(19):2070-80
pubmed: 18955635
EBioMedicine. 2020 Sep;59:102943
pubmed: 32818805
Toxicol Sci. 2013 Mar;132(1):32-42
pubmed: 23221006
Br Med J. 1959 Nov 14;2(5158):1005-6
pubmed: 13842538
Cell Rep. 2016 Feb 2;14(4):920-931
pubmed: 26804918
Nature. 2014 Jun 26;510(7506):542-6
pubmed: 24847880
Diabetes. 1981 Aug;30(8):644-9
pubmed: 7250534
Diabetes Care. 2006 Feb;29(2):254-8
pubmed: 16443869
Clin Cancer Res. 2020 Sep 15;26(18):4921-4932
pubmed: 32646922
Cell Rep. 2020 Feb 11;30(6):1735-1752.e7
pubmed: 32049007
Clin Pharmacol Ther. 2010 Dec;88(6):801-8
pubmed: 21048706
Cell Metab. 2016 Apr 12;23(4):567-8
pubmed: 27076069
Proc Natl Acad Sci U S A. 2022 Apr 5;119(14):e2122217119
pubmed: 35344434
J Invest Dermatol. 2017 Aug;137(8):1740-1748
pubmed: 28433543
Cell Metab. 2015 Oct 6;22(4):590-605
pubmed: 26365176
Diabetes Obes Metab. 2016 Jan;18(1):104-8
pubmed: 26381793
J Pharm Sci. 1972 Sep;61(9):1411-8
pubmed: 5068947
Cell Metab. 2016 Oct 11;24(4):521-522
pubmed: 27732831
J Clin Pharmacol. 1975 May-Jun;15(5-6):446-8
pubmed: 1133221
Clin Pharmacokinet. 1996 May;30(5):359-71
pubmed: 8743335
Dis Markers. 2019 Feb 10;2019:6230162
pubmed: 30881522
Nature. 2017 Aug 3;548(7665):112-116
pubmed: 28723898
Cancer Immunol Res. 2017 Jan;5(1):9-16
pubmed: 27941003
Endocr Rev. 2021 Jan 28;42(1):77-96
pubmed: 32897388
Cell Metab. 2010 May 5;11(5):390-401
pubmed: 20444419
Annu Rev Pharmacol. 1975;15:351-66
pubmed: 1096790
BMJ. 2003 Oct 25;327(7421):951-3
pubmed: 14576245
Cell Metab. 2013 Mar 5;17(3):313-4
pubmed: 23473026
Diabetes. 2017 Mar;66(3):598-612
pubmed: 27797909
Cell Metab. 2017 May 2;25(5):1147-1159.e10
pubmed: 28467931
Nat Rev Endocrinol. 2018 Jul;14(7):390-403
pubmed: 29728598
Diabetes. 2005 Jan;54(1):8-14
pubmed: 15616005
J Biol Chem. 2020 Mar 6;295(10):3330-3346
pubmed: 31974165
J Clin Invest. 1992 Oct;90(4):1323-7
pubmed: 1401068
Regul Toxicol Pharmacol. 2010 Oct;58(1):155-60
pubmed: 20488215
PLoS One. 2018 Nov 1;13(11):e0206785
pubmed: 30383866
Obes Rev. 2018 Jul;19(7):1008-1016
pubmed: 29573216
Diabetologia. 2017 Sep;60(9):1566-1576
pubmed: 28776081
J Clin Oncol. 2009 Jan 10;27(2):176-85
pubmed: 19064975
Nat Metab. 2019 Dec;1(12):1202-1208
pubmed: 32694673
Elife. 2014 May 13;3:e02242
pubmed: 24843020
Biochim Biophys Acta. 2013 Mar;1827(3):401-10
pubmed: 23220394
Cancer Metab. 2015 Oct 20;3:11
pubmed: 26500770
Nature. 2019 Nov;575(7782):380-384
pubmed: 31666695
Eur J Clin Pharmacol. 1971 Sep;3(4):221-8
pubmed: 5151304
Mol Pharmacol. 2015 Jul;88(1):75-83
pubmed: 25920679
Cell Metab. 2021 Oct 5;33(10):1974-1987.e9
pubmed: 34270929
Nature. 2009 Jul 2;460(7251):103-7
pubmed: 19494812
Cancer Res. 2007 Jul 15;67(14):6745-52
pubmed: 17638885
Cancer Res. 2007 Nov 15;67(22):10804-12
pubmed: 18006825
Jpn J Pharmacol. 1967 Sep;17(3):439-49
pubmed: 5300191
Drug Metab Pharmacokinet. 2008;23(4):243-53
pubmed: 18762711
Biochem J. 2004 Sep 15;382(Pt 3):877-84
pubmed: 15175014
Ger Med Mon. 1966 Mar;11(3):107-12
pubmed: 5326254
Nat Rev Cancer. 2006 Sep;6(9):729-34
pubmed: 16915295
N Engl J Med. 2004 Feb 12;350(7):664-71
pubmed: 14960743
J Biol Chem. 2014 Feb 28;289(9):5950-9
pubmed: 24403081
Immunity. 2015 Jan 20;42(1):41-54
pubmed: 25607458
Pharmacol Ther. 2019 Jun;198:46-58
pubmed: 30790643
Nat Med. 2017 Jul;23(7):850-858
pubmed: 28530702
Oncotarget. 2015 Nov 10;6(35):37281-99
pubmed: 26484566
Pharmacol Res. 2016 Nov;113(Pt A):675-685
pubmed: 27720766
Int J Obes (Lond). 2008 Jan;32(1):61-72
pubmed: 17653063
Cell Metab. 2018 Nov 6;28(5):679-688.e4
pubmed: 30244975
Biochem Pharmacol. 2005 Dec 5;70(12):1851-60
pubmed: 16263091
Biochem J. 2000 Jun 15;348 Pt 3:607-14
pubmed: 10839993
Clin Pharmacokinet. 1989 Feb;16(2):100-28
pubmed: 2656043
Cell Metab. 2006 Jun;3(6):393-402
pubmed: 16753575
Biomed Pharmacother. 2013 Jun;67(5):425-30
pubmed: 23582785
J Biol Chem. 2005 Jan 28;280(4):2737-44
pubmed: 15550386
J Pharm Sci. 2013 Sep;102(9):3407-17
pubmed: 23666872
Front Pharmacol. 2018 Feb 22;9:141
pubmed: 29520235
J Natl Cancer Inst. 2004 Apr 7;96(7):546-53
pubmed: 15069117
Nature. 2013 Feb 14;494(7436):256-60
pubmed: 23292513
Arzneimittelforschung. 1965 Jul;15(7):765-70
pubmed: 5898679
Cell Metab. 2014 Sep 2;20(3):526-40
pubmed: 25002183
Nat Med. 2018 Sep;24(9):1384-1394
pubmed: 30038219
Eur J Clin Pharmacol. 1979 Sep;16(3):195-202
pubmed: 499320
Cell Metab. 2010 Jun 9;11(6):554-65
pubmed: 20519126
Biomolecules. 2021 Dec 04;11(12):
pubmed: 34944478
Am J Med. 1997 Jan;102(1):99-110
pubmed: 9209206
Biomed Pharmacother. 2019 Dec;120:109458
pubmed: 31550676
Clin Cancer Res. 2016 Mar 1;22(5):1076-85
pubmed: 26459175
BMC Biol. 2016 Aug 09;14:65
pubmed: 27506389
Nature. 2020 Feb;578(7795):444-448
pubmed: 31875646
Mol Cell Biol. 2001 Aug;21(16):5471-7
pubmed: 11463829
Diabetes. 2000 Dec;49(12):2063-9
pubmed: 11118008
Proc Soc Exp Biol Med. 1957 May;95(1):190-2
pubmed: 13432032
Expert Rev Mol Med. 2012 Jan 11;14:e1
pubmed: 22233681
Cell Rep. 2019 Dec 3;29(10):3009-3018.e4
pubmed: 31801069
Cancer Cell. 2019 May 13;35(5):798-815.e5
pubmed: 31031016
Mol Cell. 2018 Aug 16;71(4):606-620.e7
pubmed: 30118680
Cell Metab. 2018 Oct 2;28(4):588-604.e5
pubmed: 30017357
Clin Breast Cancer. 2012 Jun;12(3):175-82
pubmed: 22607767
Pancreas. 2015 May;44(4):636-47
pubmed: 25875801
Cell Metab. 2014 Aug 5;20(2):197-9
pubmed: 25100057
Nat Immunol. 2020 May;21(5):555-566
pubmed: 32327756
Diabetes. 1999 Dec;48(12):2414-21
pubmed: 10580431
Cancer Res. 2020 Jun 1;80(11):2150-2162
pubmed: 32179514
Diabet Med. 1992 Jan-Feb;9(1):61-5
pubmed: 1551312
Diabetes. 2021 Jul;70(7):1575-1580
pubmed: 33849997
Nat Med. 2018 Sep;24(9):1395-1406
pubmed: 30150719
J Am Soc Nephrol. 2006 Aug;17(8):2127-35
pubmed: 16807400
Mol Cell. 2005 Apr 29;18(3):283-93
pubmed: 15866171
Cell Physiol Biochem. 2018;49(3):837-847
pubmed: 30184547
Diabetologia. 2008 Aug;51(8):1552-3
pubmed: 18528677
Curr Med Res Opin. 1984;9(1):47-51
pubmed: 6373159
Diabetologia. 2012 Feb;55(2):443-9
pubmed: 22009334
Science. 2005 Dec 9;310(5754):1642-6
pubmed: 16308421
Cell. 2006 Feb 10;124(3):471-84
pubmed: 16469695
Proc Natl Acad Sci U S A. 2015 Feb 10;112(6):1809-14
pubmed: 25624476
J Biol Chem. 2000 Jan 7;275(1):223-8
pubmed: 10617608

Auteurs

Laura Di Magno (L)

Department of Molecular Medicine, Sapienza University of Rome, 00189 Rome, Italy.

Fiorella Di Pastena (F)

Department of Molecular Medicine, Sapienza University of Rome, 00189 Rome, Italy.

Rosa Bordone (R)

Department of Molecular Medicine, Sapienza University of Rome, 00189 Rome, Italy.

Sonia Coni (S)

Department of Molecular Medicine, Sapienza University of Rome, 00189 Rome, Italy.

Gianluca Canettieri (G)

Department of Molecular Medicine, Sapienza University of Rome, 00189 Rome, Italy.
Istituto Pasteur-Fondazione Cenci-Bolognetti, 00161 Rome, Italy.

Classifications MeSH